Researchers at UCLA Health and UC San Francisco have identified a natural defense mechanism in brain cells that helps remove toxic tau protein, potentially explaining why some neurons resist Alzheimer's damage better than others. The study, published in Cell, used CRISPR screening on lab-grown human neurons to uncover this system. Findings suggest new therapeutic avenues for neurodegenerative diseases.
Scientists have pinpointed a protein complex called CRL5SOCS4 that acts as a cleanup crew for tau, the toxic protein central to Alzheimer's disease and related dementias. Tau accumulation damages neurons, leading to cell death, but some brain cells show greater resilience. The research team employed CRISPRi, a gene-silencing tool, to test nearly every human gene's impact on tau buildup in neurons derived from human stem cells.
The screen revealed that CRL5SOCS4 tags tau with molecular markers, directing it to the cell's waste disposal system for breakdown. In brain tissue from Alzheimer's patients, neurons with elevated levels of CRL5SOCS4 components were more likely to survive amid tau presence. "We wanted to understand why some neurons are vulnerable to tau accumulation while others are more resilient," said Dr. Avi Samelson, first author and assistant professor of Neurology at UCLA Health, who led the work at UCSF. "By systematically screening nearly every gene in the human genome, we found both expected pathways and completely unexpected ones that control tau levels in neurons."
An additional finding linked mitochondrial stress—disruptions in the cell's energy producers—to the production of a harmful 25-kilodalton tau fragment, known as NTA-tau, detected in Alzheimer's patients' fluids. This fragment emerges under oxidative stress, impairing the proteasome's tau processing and altering protein clustering. "This tau fragment appears to be generated when cells experience oxidative stress, which is common in aging and neurodegeneration," Samelson noted.
The study highlights potential treatments, such as enhancing CRL5SOCS4 activity or safeguarding the proteasome during stress. It also identified other pathways, like UFMylation and membrane anchor enzymes, not previously linked to tau. Conducted with neurons carrying disease-causing mutations, the research was funded by the Rainwater Charitable Foundation/Tau Consortium and the National Institutes of Health. Researchers emphasize that further studies are required to develop therapies.
